Novo Nordisk

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Novo Nordisk and other ETFs, options, and stocks.

About NVO

Novo Nordisk A/S is a global healthcare company, which engages in the discovery, development, manufacturing and marketing of pharmaceutical products. It operates through the Diabetes and Obesity Care and Rare Disease segments. 

CEO
Maziar Mike Doustdar
CEOMaziar Mike Doustdar
Employees
68,794
Employees68,794
Headquarters
Bagsværd, Capital Region
HeadquartersBagsværd, Capital Region
Founded
1923
Founded1923
Employees
68,794
Employees68,794

NVO Key Statistics

Market cap
224.50B
Market cap224.50B
Price-Earnings ratio
12.07
Price-Earnings ratio12.07
Dividend yield
2.39%
Dividend yield2.39%
Average volume
9.17M
Average volume9.17M
High today
$51.40
High today$51.40
Low today
$50.26
Low today$50.26
Open price
$51.03
Open price$51.03
Volume
7.02M
Volume7.02M
52 Week high
$71.80
52 Week high$71.80
52 Week low
$35.12
52 Week low$35.12

NVO News

TipRanks 2h
Novo Nordisk’s CagriSema Trial Wraps Up: What Completed Phase 3 Data Could Mean for NVO

Novo Nordisk (NVO) announced an update on their ongoing clinical study. TipRanks has entered a new arena in the investing world, powering the index of an ETF b...

Simply Wall St 8h
Novo Nordisk Wins EU Approval For Oral And Higher Dose Wegovy

Novo Nordisk (NYSE:NVO) has received European Commission marketing authorization for oral Wegovy for weight management across the EU. The EC also approved high...

Novo Nordisk Wins EU Approval For Oral And Higher Dose Wegovy
TipRanks 1d
Cboe data shows mixed options sentiment in Novo Nordisk with shares up 2.11%

Cboe data shows mixed options sentiment in Novo Nordisk (NVO), with shares up $1.06, or 2.11%, near $51.62. Options volume running well above average with 56k c...

Analyst ratings

57%

of 37 ratings
Buy
37.8%
Hold
56.8%
Sell
5.4%

More NVO News

Nasdaq 1d
NVO Stock Up on EC Approval of Wegovy Pill to Treat Obesity

Novo Nordisk NVO received a boost after the European Commission (EC) approved once-daily oral version of Wegovy (semaglutide 25 mg) for the treatment of adults...

NVO Stock Up on EC Approval of Wegovy Pill to Treat Obesity
Benzinga 2d
Wegovy Pill in Europe - Novo Nordisk Expands Franchise With First European Approval for Oral Weight Loss Drug

The approval makes Wegovy the first GLP-1 receptor agonist available in tablet form for weight management across all European Union member states. It follows a...

Wegovy Pill in Europe - Novo Nordisk Expands Franchise With First European Approval for Oral Weight Loss Drug
TipRanks 2d
Novo Nordisk Expands Cardiometabolic Reach With New Heart Failure–Obesity Trial

Novo Nordisk (NVO) announced an update on their ongoing clinical study. TipRanks has entered a new arena in the investing world, powering the index of an ETF b...

Simply Wall St 2d
Following Buyback Update Is Novo Nordisk Still Below Fair Value?

Advertisement Share repurchase update gives investors fresh data point Novo Nordisk (NVO) has updated investors on its ongoing share repurchase programme, wit...

Following Buyback Update Is Novo Nordisk Still Below Fair Value?
The Wall Street Journal 3d
In the Weight-Loss Wars, Novo’s Obesity Pill Is Pulling Way Ahead of Lilly’s

Novo Nordisk’s Wegovy pill is the market leader for new oral weight-loss drugs. George Frey / Bloomberg News The launch of weight-loss pills is the hottest bat...

In the Weight-Loss Wars, Novo’s Obesity Pill Is Pulling Way Ahead of Lilly’s
TipRanks 4d
Novo Nordisk Ramps Up Share Buybacks Under DKK 15 Billion Programme

TipRanks has entered a new arena in the investing world, powering the index of an ETF based on its unique data now trading under the ticker RANK on the NYSE. R...

Benzinga 4d
Novo Nordisk Shares Encouraging Long-Term Data From Hemophilia Program

Novo Nordisk A/S (NYSE:NVO) on Saturday presented new phase 3 data supporting the long-term safety and efficacy of investigational hemophilia A treatment deneci...

Novo Nordisk Shares Encouraging Long-Term Data From Hemophilia Program

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.